通化东宝(600867.SH)：甘精胰岛素注射液获得境外上市许可

Core Viewpoint - Tonghua Dongbao (600867.SH) has received approval from the Ministry of Health of the Republic of the Union of Myanmar for the marketing license of its product, Insulin Glargine Injection [1] Company Summary - Insulin Glargine is a long-acting insulin analog that requires daily injection, with an onset of action that lasts for 24 hours [1] - The product is designed to provide a stable reduction in blood glucose levels without peak concentrations [1]